Literature DB >> 2825693

Sodium butyrate activates human immunodeficiency virus long terminal repeat--directed expression.

C Bohan1, D York, A Srinivasan.   

Abstract

To study the effect of sodium butyrate on human immunodeficiency virus (HIV) long terminal repeat (LTR)--directed expression, we constructed a chimeric plasmid (pLTR-CAT) in which the LTR sequences derived from a molecular clone of HIV were fused to the chloramphenicol acetyltransferase (CAT) gene. We used transient expression assays in transfected tissue culture cells to monitor the activity of the LTR. The expression of the pLTR-CAT plasmid was activated when the cells were exposed to butyrate after transfection. The magnitude of butyrate-induced increase was linear up to an 8 mM concentration and was different with regard to the target promoters used. Recombinant plasmids linked to marker genes may be useful models for studying the effects on HIV of various agents of chemical and biological origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825693     DOI: 10.1016/s0006-291x(87)80217-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate.

Authors:  C J Frégeau; C D Helgason; R C Bleackley
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

2.  Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.

Authors:  A Tempaku; Y Maeda; W Song; S Harada
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

3.  The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.

Authors:  Mary E Manson McManamy; Shweta Hakre; Eric M Verdin; David M Margolis
Journal:  Antivir Chem Chemother       Date:  2014-01-29

5.  n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses.

Authors:  F F Shadan; L M Cowsert; L P Villarreal
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Authors:  Mahesh Chemudupati; Adam D Kenney; Anna C Smith; Robert J Fillinger; Lizhi Zhang; Ashley Zani; Shan-Lu Liu; Matthew Z Anderson; Amit Sharma; Jacob S Yount
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Cell line-dependent variability in HIV activation employing DNMT inhibitors.

Authors:  Guerau Fernandez; Steven L Zeichner
Journal:  Virol J       Date:  2010-10-13       Impact factor: 4.099

Review 8.  Chromatin dynamics associated with HIV-1 Tat-activated transcription.

Authors:  Rebecca Easley; Rachel Van Duyne; Will Coley; Irene Guendel; Sherry Dadgar; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  Biochim Biophys Acta       Date:  2009-08-27

9.  Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.

Authors:  W Tadmori; D Mondal; I Tadmori; O Prakash
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system.

Authors:  R E Sutton; D R Littman
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.